The document provides an overview of the Regional Bioequivalence Centre (RBEC) in Ethiopia, including its background, organization, facilities, study protocols, operations, and challenges. RBEC was established in 2012 through a public-private partnership to conduct bioequivalence studies for East African pharmaceutical manufacturers. It has a bioanalytical laboratory, clinical study center, and standard operating procedures. RBEC has completed three pilot studies and aims to expand services and customer satisfaction through a business plan. However, it faces challenges around funding, low production capacity, and lack of clear governance that need to be addressed for long-term viability.